Compare the effect of walnut leaves and metformin on blood sugar, cholesterol and liver enzyme type II diabetics - Trial IRCT20170612034484N1
Access comprehensive clinical trial information for IRCT20170612034484N1 through Pure Global AI's free database. This Phase 1 trial is sponsored by Investigator and is currently Completed. The study focuses on Non-insulin-dependent diabetes mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
IRCT20170612034484N1
Phase 1
Completed
drug
Trial Details
Iranian Registry Of Clinical Trial • IRCT20170612034484N1
Compare the effect of walnut leaves and metformin on blood sugar, cholesterol and liver enzyme type II diabetics
Comparison of Capsule extract of walnut leaves and metformin on blood sugar, cholesterol and liver enzyme type II diabetics
Study Focus
Sponsor & Location
Investigator
Iran
Timeline & Enrollment
Phase 1
Apr 30, 2017
N/A
ICD-10 Classifications
Other specified diabetes mellitus without complications
Unspecified diabetes mellitus without complications
Other specified diabetes mellitus
Other specified diabetes mellitus with other specified complications
Other specified diabetes mellitus with unspecified complications
Data Source
Iranian Registry Of Clinical Trial
IRCT20170612034484N1
Non-Device Trial